Ponatinib (AP24534)

Catalog No.S1490

Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.

Price Stock Quantity  
USD 100 In stock
USD 110 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Ponatinib (AP24534) Chemical Structure

Ponatinib (AP24534) Chemical Structure
Molecular Weight: 532.56

Validation & Quality Control

2 customer reviews :

Quality Control & MSDS

Related Compound Libraries

Bcr-Abl Inhibitors with Unique Features

  • Selective Bcr-Abl Inhibitor

    Nilotinib (AMN-107) Bcr-Abl-selective, IC50<30 nM.

  • Most Potent Bcr-Abl Inhibitor

    GZD824 Bcr-Abl(WT), IC50=0.34 nM; Bcr-Abl(T315I), IC50=0.68 nM.

  • FDA-approved Bcr-Abl Inhibitor

    Dasatinib Approved by FDA for CML and Ph+ ALL.

  • Newest Bcr-Abl Inhibitor

    GZD824 Orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Product Information

  • Compare Bcr-Abl Inhibitors
    Compare Bcr-Abl Products
  • Research Area
  • Ponatinib (AP24534) Mechanism

Product Description

Biological Activity

Description Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.
Targets Abl [1]
(Cell-free assay)
PDGFRα [1]
(Cell-free assay)
VEGFR2 [1]
(Cell-free assay)
FGFR1 [1]
(Cell-free assay)

 View  More

IC50 0.37 nM 1.1 nM 1.5 nM 2.2 nM
In vitro AP24534 potently inhibits native Abl, AblT315I, and other clinically important Abl kinase domain mutants with IC50 of 0.30 nM–2 nM. AP24534 doesn't inhibit Aurora kinase family members, nor does it inhibit insulin receptor or CDK2/cyclin E. AP24534 inhibits proliferation of Ba/F3 cells expressing Bcr-Abl with IC50 of 0.5 nM, as well as Ba/F3 cells expressing a range of Bcr-Abl mutants with IC50 of 0.5 nM–36 nM. The inhibition of proliferation by AP24534 is correlated with induction of apoptosis. [1-2] In leukemic cell lines containing activated forms of FLT3, KIT, FGFR1, and PDGFRα receptors, AP24534 potently inhibits receptor phosphorylation and cellular proliferation with IC50 of 0.3 nM to 20 nM. In MV4-11 (FLT3-ITD(+/+)) but not RS4;11 (FLT3-ITD(–/–)) AML cells, AP24534 inhibits FLT3 signaling and induced apoptosis at less than 10 nM. AP24534 inhibits viability of primary leukemic blasts from a FLT3-ITD positive AML patient with IC50 of 4 nM but not those from patients with AML expressing native FLT3. [3] In Ba/F3 cells engineered to express activated FGFR1-4, AP24534 potently inhibits FGFR-mediated signaling and viability with IC50 lower than 40 nM. In cell lines representing multiple tumor types (endometrial, bladder, gastric, breast, lung, and colon), and containing FGFRs dysregulated by a variety of mechanisms, AP24534 inhibits FGFR-mediated signaling with IC50 less than 40 nM and inhibits cell growth with IC50 of 7 nM–181 nM. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
EoL-1-cellNF;vN4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEDTUG9KSzVyPUCuNFAxODByMEO1PUDPxE1?NXTkUmpVW0GQR1XS
MV-4-11M1v0Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPTTWM2OD1yLkCwNFA6PTZizszNNXfEfYExW0GQR1XS
MEG-01NXW5S4xpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUDN[Ip5UUN3ME2wMlAxODF{ODFOwG0>NF7kWYxUSU6JRWK=
LAMA-84MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmPnTWM2OD1yLkCwNFE3PSEQvF2=NIPlOoRUSU6JRWK=
CGTH-W-1NXPGOnliT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYD4VXo2UUN3ME2wMlAxOTZ7IN88US=>MljvV2FPT0WU
KASUMI-1NUDXTIxjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnm0TWM2OD1yLkCwNlE4KM7:TR?=NWO3SJgxW0GQR1XS
BE-13MkfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2jROmlEPTB;MD6wNFI2QSEQvF2=MlHSV2FPT0WU
CTV-1NE\sbXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGDRS4pKSzVyPUCuNFA2OjFizszNNULrSoc2W0GQR1XS
NKM-1NEHSbXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MULJR|UxRTBwMEC2OVUh|ryPNXSxbXJCW0GQR1XS
MONO-MAC-6M2P6dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\WTWM2OD1yLkCwPFM4KM7:TR?=MVnTRW5ITVJ?
A204NF;GVYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlHvTWM2OD1yLkCxNlE5KM7:TR?=NVv5SFNqW0GQR1XS
GDM-1M1zwSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MULJR|UxRTBwMEG4N|Mh|ryPMn\1V2FPT0WU
AN3-CAM{\0d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVPSRppFUUN3ME2wMlAyQDd|IN88US=>NH\pR4hUSU6JRWK=
BL-70M4O1U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4TaVGlEPTB;MD6wNlE6QSEQvF2=NIH4ToVUSU6JRWK=
DaudiNF\0d5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MknTTWM2OD1yLkCyOVM4KM7:TR?=MkLzV2FPT0WU
KU812MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXrJR|UxRTBwMEK4OFgh|ryPM1rr[HNCVkeHUh?=
KG-1M{Dre2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4j5R2lEPTB;MD6wN|I6PCEQvF2=M1v2XXNCVkeHUh?=
DOHH-2NX6yTJg3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4LRemlEPTB;MD6wOFgxOyEQvF2=M1TMd3NCVkeHUh?=
HuO9NGPMNndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEHkOGVKSzVyPUCuNFU1PDhizszNNFvXRWRUSU6JRWK=
EB2NUL5dWFpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX3JR|UxRTBwMEW1O|Yh|ryPMknFV2FPT0WU
G-402M3Pn[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVnJR|UxRTBwME[zOFEh|ryPNUjXboxKW0GQR1XS
SU-DHL-1NX7se3BnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2Tv[WlEPTB;MD6wOlM4QSEQvF2=NHG1T2xUSU6JRWK=
NCI-H719NYDXUmJnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTBwMEe4PFgh|ryPMnvvV2FPT0WU
MLMAM2XlcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTBwMEmwOkDPxE1?MUTTRW5ITVJ?
KM12Mk\6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV7JR|UxRTBwMEm3N|ch|ryPMUjTRW5ITVJ?
SUP-T1NYPFR5ExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3fJN2lEPTB;MD6wPVk5OiEQvF2=MU\TRW5ITVJ?
MZ1-PCMnPvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWTJR|UxRTBwMUGzN|Yh|ryPNV64SFJXW0GQR1XS
MFE-296NYGwTW91T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEDXTHBKSzVyPUCuNVE5OzlizszNM4C4SXNCVkeHUh?=
ALL-PONIW1O|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTBwMUK0OFMh|ryPM{C1XHNCVkeHUh?=
GB-1MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3TpWmlEPTB;MD6xNlUyOiEQvF2=MlHwV2FPT0WU
SIG-M5NUPxXpRST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV;JR|UxRTBwMUOzO{DPxE1?MWXTRW5ITVJ?
P30-OHKNIi3U|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4jXVWlEPTB;MD6xOVY4OiEQvF2=NGnQUJlUSU6JRWK=
NCI-H716NVr3[YNVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkPETWM2OD1yLkG2NlY3KM7:TR?=MXHTRW5ITVJ?
MPP-89MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrOSGVKSzVyPUCuNVY6OzNizszNMoXnV2FPT0WU
SF126NHuxTZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml7aTWM2OD1yLkG3NFY{KM7:TR?=NIm5ZWhUSU6JRWK=
CTB-1MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRTBwMUezNVYh|ryPNWnYU5pJW0GQR1XS
CA46NHLiUVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTBwMUe0PFkh|ryPMnj0V2FPT0WU
NCI-H520M2PiPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmrVTWM2OD1yLkG3O|MzKM7:TR?=NUTiT3dLW0GQR1XS
CAL-85-1NIP6R3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlX1TWM2OD1yLkG3PVI4KM7:TR?=NEXSSWhUSU6JRWK=
NCI-H2342NWTDdoh6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3e0[mlEPTB;MD6xPFU4PyEQvF2=NViyXFJ[W0GQR1XS
697NHfsZoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIPmV4lKSzVyPUCuNVg5PzFizszNMknaV2FPT0WU
NYMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTBwMUmyPFch|ryPNV61VFY1W0GQR1XS
T98GNF:0dYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvqR4IxUUN3ME2wMlE6OzF6IN88US=>MY\TRW5ITVJ?
NCI-H1703MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUjJR|UxRTBwMUm2NVUh|ryPMnPwV2FPT0WU
NCI-H2087M{D2Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHvufFJKSzVyPUCuNlA1OzlizszNNGf4cItUSU6JRWK=
PF-382MnrSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTBwMkC4O|Mh|ryPM4DvPXNCVkeHUh?=
HCT-116MnrRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmHCTWM2OD1yLkKxNFY6KM7:TR?=MnXYV2FPT0WU
CAKI-1MnW2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MULJR|UxRTBwMkG2OlYh|ryPNYDOPYFOW0GQR1XS
CCF-STTG1MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUG2TYxnUUN3ME2wMlIzPDd3IN88US=>MYLTRW5ITVJ?
D-392MGNYHDemVKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M176R2lEPTB;MD6yN|E4PyEQvF2=NYjkTYRSW0GQR1XS
RT-112M3qySGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoCwTWM2OD1yLkKzO|k2KM7:TR?=MUXTRW5ITVJ?
MES-SAM3\YPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{DpTmlEPTB;MD6yOFE5PyEQvF2=MY\TRW5ITVJ?
LC-2-adM4TqOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWWyVYptUUN3ME2wMlI1OjZ3IN88US=>MortV2FPT0WU
NOS-1M1WyVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVrJR|UxRTBwMkSzOlch|ryPNFvS[VBUSU6JRWK=
NALM-6MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYjjb4RuUUN3ME2wMlI2PTR|IN88US=>M1HtdHNCVkeHUh?=
TE-15NHTrXmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFm2Z5ZKSzVyPUCuNlYxQTFizszNM4DEfnNCVkeHUh?=
786-0NYrvPY95T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFS3VG5KSzVyPUCuNlYzOjhizszNNInJO|dUSU6JRWK=
IST-MES1NW\xS4RwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{O0PGlEPTB;MD6yOlgzQSEQvF2=MnjmV2FPT0WU
KYSE-180NX;aU|h1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mmj5TWM2OD1yLkK2PFkyKM7:TR?=NFT4OIlUSU6JRWK=
YTNHjpbo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYHJR|UxRTBwMk[5O|Qh|ryPM{jNcHNCVkeHUh?=
A427NV75dJF2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWPJR|UxRTBwMkeyOlQh|ryPNYDne2xNW0GQR1XS
KYSE-450M2ezXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFjnZ2xKSzVyPUCuNlc{OjlizszNMWXTRW5ITVJ?
HuH-7MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwMke3OlMh|ryPMX3TRW5ITVJ?
CAS-1NX;WdZZuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWPPOlVVUUN3ME2wMlI5OzB|IN88US=>NFzoeGZUSU6JRWK=
KURAMOCHIM3;MS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWnJR|UxRTBwMki0NVkh|ryPM{\rSHNCVkeHUh?=
ACHNMXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX36c3RiUUN3ME2wMlI6OzJ|IN88US=>NULNPYF1W0GQR1XS
HGC-27NIeyUXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXfJR|UxRTBwMkmzOVMh|ryPMUPTRW5ITVJ?
A172NGT1dpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIjYd2xKSzVyPUCuNlk2PzdizszNMXXTRW5ITVJ?
SNU-449NXTj[ldbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3H2OGlEPTB;MD6yPVk3PCEQvF2=MmjSV2FPT0WU
SW982NUnY[2tpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkC4TWM2OD1yLkK5PVc5KM7:TR?=M37HVHNCVkeHUh?=
EFO-21NIHkOG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2XSN2lEPTB;MD6zNFQyOSEQvF2=M1LGbHNCVkeHUh?=
NCI-H2030M1HnWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7jTWM2OD1yLkOxNVY1KM7:TR?=M1LqbnNCVkeHUh?=
HT-144MoDZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1e5V2lEPTB;MD6zNVI5KM7:TR?=Mk\oV2FPT0WU
MFE-280M1[wfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIL5SYlKSzVyPUCuN|E1PTNizszNNGPHPYFUSU6JRWK=
SK-LU-1MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXjkWodMUUN3ME2wMlMyPDZ4IN88US=>MWrTRW5ITVJ?
NCI-H2052NIj3[oJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGDYS3pKSzVyPUCuN|E1QDRizszNMorOV2FPT0WU
SK-HEP-1NFi2OpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVzmZVRqUUN3ME2wMlM{OzZ6IN88US=>NFSzbJVUSU6JRWK=
QIMR-WILMWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVzMcnltUUN3ME2wMlM{PDJ2IN88US=>MoLoV2FPT0WU
A2780MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1Xke2lEPTB;MD6zOFMxPCEQvF2=NVLxV3pHW0GQR1XS
ACNMo\6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUPJR|UxRTBwM{S4O|Mh|ryPNFrPZXBUSU6JRWK=
BxPC-3MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MonoTWM2OD1yLkO0PVg6KM7:TR?=M2CwdXNCVkeHUh?=
BCPAPMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml7ITWM2OD1yLkO2NFAyKM7:TR?=MoW3V2FPT0WU
HOP-62MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlvFTWM2OD1yLkO2NVA3KM7:TR?=MnTkV2FPT0WU
SW1710NIPQU4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEm2SpFKSzVyPUCuN|Y1PTVizszNM2S2e3NCVkeHUh?=
OPM-2MoDwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHztWXhKSzVyPUCuN|Y1PzNizszNNISweYhUSU6JRWK=
DBTRG-05MGM{TvTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIPWZVhKSzVyPUCuN|gxPTRizszNMXTTRW5ITVJ?
SK-MEL-24Ml64S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEThUmNKSzVyPUCuN|k4QTFizszNMnHxV2FPT0WU
8305CNWj2O|dtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm\vTWM2OD1yLkO5O|k{KM7:TR?=NV;qfYp7W0GQR1XS
OVCAR-4M3HwTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX7rUmg5UUN3ME2wMlQyPTh4IN88US=>M3vUVXNCVkeHUh?=
HLENEnDe4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVrhN5lNUUN3ME2wMlQyQDZizszNNXXuZ2RGW0GQR1XS
NCI-H747MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWHwN4tGUUN3ME2wMlQzOTN5IN88US=>MlnFV2FPT0WU
SW780M{KyN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEWxb|RKSzVyPUCuOFI{PDZizszNMmDYV2FPT0WU
KYSE-150NXrOWXNnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTBwNEK0NVUh|ryPM4XvWXNCVkeHUh?=
H4M2HuNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MonKTWM2OD1yLkSyOFUyKM7:TR?=M2rKcnNCVkeHUh?=
SW1088MlHkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXnWUZF[UUN3ME2wMlQ1OzlizszNMVfTRW5ITVJ?
SF268MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWrCfotUUUN3ME2wMlQ1QDZizszNNWDxTI9pW0GQR1XS
RT4NEC0[o1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MneyTWM2OD1yLkS1NVEyKM7:TR?=M4DPV3NCVkeHUh?=
NCI-H522NWOxUpBmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXmyXWNSUUN3ME2wMlQ2OjdizszNNYr5O49FW0GQR1XS
LCLC-97TM1NHjZN2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HtSmlEPTB;MD60OlE6PSEQvF2=MVfTRW5ITVJ?
CAL-39M4PzSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mnq4TWM2OD1yLkS2OVE6KM7:TR?=NVXWOlg{W0GQR1XS
CAL-120MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXjQWFBoUUN3ME2wMlQ4PjR|IN88US=>NXvofJRmW0GQR1XS
ESS-1M2[yZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEfPVnFKSzVyPUCuOFc5OjFizszNMlnyV2FPT0WU
KARPAS-45MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLqTWM2OD1yLkS4PVM{KM7:TR?=NETK[lhUSU6JRWK=
DU-4475NY\WPJc6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXPJR|UxRTBwNEm1NVEh|ryPMVLTRW5ITVJ?
VMRC-RCZNYL1S2MxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TaTWlEPTB;MD60PVkxPCEQvF2=MWDTRW5ITVJ?
HOSMlm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvZVVBKSzVyPUCuOVA{PjVizszNM4HNeHNCVkeHUh?=
MOLT-16MnnxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2\wbGlEPTB;MD61NVgxQCEQvF2=M4WyPXNCVkeHUh?=
RPMI-6666NYj4R2lOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mo\NTWM2OD1yLkWyNVM2KM7:TR?=M1riTHNCVkeHUh?=
K052MoHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIHmWXdKSzVyPUCuOVIyPCEQvF2=NVTEOpM4W0GQR1XS
EHEBMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkS2TWM2OD1yLkWyNVgzKM7:TR?=M3nuTHNCVkeHUh?=
MFH-inoNWDXVZZbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGPCUJRKSzVyPUCuOVI{PTFizszNM2W3S3NCVkeHUh?=
A4-FukM1XtdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYfLPVY5UUN3ME2wMlUzPTJ6IN88US=>NHroOJhUSU6JRWK=
SW1417NV20TYRLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYG0bmlNUUN3ME2wMlUzPzhzIN88US=>MknqV2FPT0WU
DoTc2-4510NXy3eG06T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4jDfWlEPTB;MD61OFk2QCEQvF2=NV;jZWJvW0GQR1XS
TE-12M4WzVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTBOJhHUUN3ME2wMlU2PzN3IN88US=>NHX1OJJUSU6JRWK=
8-MG-BAMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2G2VGlEPTB;MD61OlA2PiEQvF2=NWW2ZnlsW0GQR1XS
ECC12Mnf6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTWTWM2OD1yLkW2OVU5KM7:TR?=MVXTRW5ITVJ?
CHL-1Ml3ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXrJR|UxRTBwNUe0OlMh|ryPMofZV2FPT0WU
LCLC-103HNWGzfo45T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkPITWM2OD1yLkW4N|Q1KM7:TR?=M1juZXNCVkeHUh?=
OS-RC-2MnHKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3m4dmlEPTB;MD61PFM4QSEQvF2=M4G5OHNCVkeHUh?=
RO82-W-1NWn4SG54T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUfONlJyUUN3ME2wMlU6PjF3IN88US=>NXzmfZNkW0GQR1XS
A3-KAWM37jU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MorzTWM2OD1yLk[xOFY4KM7:TR?=MWLTRW5ITVJ?
NCCITNH[zeVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjqTWM2OD1yLk[xO|E2KM7:TR?=Mnr1V2FPT0WU
IST-SL2Mm\2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3nRUmlEPTB;MD62NlUzOiEQvF2=M4rjNHNCVkeHUh?=
GI-ME-NMkXmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTBwNkOwOlkh|ryPM3zrSXNCVkeHUh?=
ES6NW\HeWd4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUSxe2V{UUN3ME2wMlY{Ojl3IN88US=>M3q4dHNCVkeHUh?=
BL-41NGXGclNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3jSUGlEPTB;MD62N|M2OiEQvF2=Mn72V2FPT0WU
Ca-SkiMUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTBwNkS4NUDPxE1?NUDIT|JPW0GQR1XS
HOP-92NYjPfZNqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkPOTWM2OD1yLk[1OlczKM7:TR?=NH3DeZRUSU6JRWK=
SK-LMS-1MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HZbGlEPTB;MD62OlQ4KM7:TR?=NXvybo43W0GQR1XS
EW-13M3nwOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{HoTmlEPTB;MD62Olc4QSEQvF2=MYPTRW5ITVJ?
647-VM{fOd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYnJR|UxRTBwNkixOFgh|ryPMXLTRW5ITVJ?
JiyoyeP-2003NG\Id|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3JR|UxRTBwNkm3N|gh|ryPMlSzV2FPT0WU
WSU-NHLMlz0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWL3cJI6UUN3ME2wMlcxQDh5IN88US=>NX:1fFE{W0GQR1XS
U-698-MNYO5O4FuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2rGUmlEPTB;MD63NVA3OyEQvF2=NHnxboVUSU6JRWK=
HC-1M{DGU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPuTWM2OD1yLkeyOFA2KM7:TR?=MV;TRW5ITVJ?
8505CMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{DtUWlEPTB;MD63Nlc1OSEQvF2=NXnDdpFnW0GQR1XS
HUTU-80NXXjboNlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{Xrb2lEPTB;MD63N|M1QSEQvF2=NHrudYVUSU6JRWK=
LB1047-RCCMVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1;UWWlEPTB;MD63N|U{QCEQvF2=NYPmZWpXW0GQR1XS
GAMGNUL2fHBmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH7YUGlKSzVyPUCuO|M3PTNizszNMlTQV2FPT0WU
CAL-12TMYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEXhR|BKSzVyPUCuO|M5PzdizszNMn3FV2FPT0WU
NCI-SNU-1M4PwNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXnu[IdQUUN3ME2wMlc4Ojd6IN88US=>MUDTRW5ITVJ?
HTC-C3NFzFfWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXHJR|UxRTBwN{e0OVEh|ryPMUjTRW5ITVJ?
HPAF-IIMlrOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYrJR|UxRTBwN{e1NFEh|ryPMUfTRW5ITVJ?
KGNMn\MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkLuTWM2OD1yLke4NFgyKM7:TR?=NHfjWVVUSU6JRWK=
EFO-27NEHWdWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmXWTWM2OD1yLke4O|M{KM7:TR?=NFHmZYhUSU6JRWK=
MEL-HOMmXiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlXCTWM2OD1yLke5OFQ6KM7:TR?=NWr5fWxLW0GQR1XS
KYSE-270MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTBwOEC1Nlkh|ryPMnfMV2FPT0WU
NCI-H1755MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkTMTWM2OD1yLkiwO|E1KM7:TR?=MVfTRW5ITVJ?
MFM-223Mkm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXPJR|UxRTBwOEG0NFch|ryPNVrWSWQ6W0GQR1XS
G-361MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTBwOEG4PVch|ryPNYjZWlhHW0GQR1XS
ETK-1NXXD[IpbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M321TWlEPTB;MD64NlQ1OSEQvF2=M3HISHNCVkeHUh?=
LU-99AMl3zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1HycGlEPTB;MD64OFcxOSEQvF2=NFXnem5USU6JRWK=
IST-MEL1NFe2[VhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFfVRnFKSzVyPUCuPFU4OzJizszNMnjxV2FPT0WU
L-540NEPTNnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHjZPY9KSzVyPUCuPFU5ODFizszNM17DbXNCVkeHUh?=
U-2-OSNFr5NGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4P3TGlEPTB;MD64OVg1PiEQvF2=NEG4XndUSU6JRWK=
HT-1376MmDFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MniwTWM2OD1yLki2NFUyKM7:TR?=MXXTRW5ITVJ?
COLO-680NM4jDPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYHneWZFUUN3ME2wMlg4QTN|IN88US=>NG\zboRUSU6JRWK=
NCI-H1581MmjrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;XSmlEPTB;MD64PVI6PyEQvF2=Mn;rV2FPT0WU
HuCCT1MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTBwOEm1OFgh|ryPMn[2V2FPT0WU
BB30-HNCMmrjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NITETolKSzVyPUCuPVI1PjlizszNM17jUXNCVkeHUh?=
NCI-H2347Mli0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIHC[oxKSzVyPUCuPVMzQTJizszNNHHT[|JUSU6JRWK=
G-401NXT2c2syT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV\6fJpNUUN3ME2wMlk{Pjl3IN88US=>M4qwRXNCVkeHUh?=
NCI-H358NFK5XJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXHUSWFyUUN3ME2wMlk2ODF2IN88US=>NILKNm5USU6JRWK=
HCC1395NV;5ZYx3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIPYdHNKSzVyPUCuPVU1PjFizszNMULTRW5ITVJ?
J82NVnTbm52T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH72d|FKSzVyPUCuPVU2PDNizszNM3rxUnNCVkeHUh?=
KE-37M4r4eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUXvd2hoUUN3ME2wMlk3Ozh5IN88US=>NIDqfIhUSU6JRWK=
NOMO-1NX25bmtmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{Xsc2lEPTB;MD65OlU3PCEQvF2=M3fVPXNCVkeHUh?=
ML-2MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkKxTWM2OD1yLkm5O|Uh|ryPM4TpXHNCVkeHUh?=
SW872Ml:5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVrJR|UxRTBwOUm3O|Uh|ryPMoTuV2FPT0WU
KYSE-520NWHSNGtPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWjJR|UxRTFwMEC0PVQh|ryPNXjVfotvW0GQR1XS
HL-60NITlOHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1GyeGlEPTB;MT6wNFk4KM7:TR?=NWPZNHloW0GQR1XS
HDLM-2MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTFwMEGyOVIh|ryPM3H3OHNCVkeHUh?=
MIA-PaCa-2MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGHlU2RKSzVyPUGuNFE{PzVizszNMULTRW5ITVJ?
TCCSUPMmnZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml3WTWM2OD1zLkCxO|MzKM7:TR?=NFPKRmlUSU6JRWK=
SH-4NF;GOmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkPiTWM2OD1zLkCyNlQ1KM7:TR?=M1HxfnNCVkeHUh?=
MG-63MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTFwMEK2NVYh|ryPMl;kV2FPT0WU
NB6NH7kdoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1voVmlEPTB;MT6wN|ExQSEQvF2=NGm2bYNUSU6JRWK=
CAL-54MoWxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHnhR5FKSzVyPUGuNFM6PTlizszNNILzOWhUSU6JRWK=
DU-145MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYTJR|UxRTFwMEiwO|Mh|ryPMkTQV2FPT0WU
HCE-4NFnlPGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWPaflRFUUN3ME2xMlA6Ojh4IN88US=>MUXTRW5ITVJ?
U-266MonBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFTNe4xKSzVyPUGuNFk3OzNizszNMXPTRW5ITVJ?
HT-1197M3HPbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX3Ffm57UUN3ME2xMlEyPDN6IN88US=>M3Gx[nNCVkeHUh?=
EW-1MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkTsTWM2OD1zLkG0NVI5KM7:TR?=NWjqT3dnW0GQR1XS
MHH-NB-11MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIf5O5FKSzVyPUGuNVU{PjhizszNM3flT3NCVkeHUh?=
NCI-H2405NIrMZVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1XBe2lEPTB;MT6xOlE3KM7:TR?=NUjmTYZEW0GQR1XS
COLO-668M4\jfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MW\JR|UxRTFwMU[0PUDPxE1?MYnTRW5ITVJ?
IMR-5NVrub3VOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV:2e21vUUN3ME2xMlE3QTN4IN88US=>NGO5XHlUSU6JRWK=
ARH-77M4fVcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXTJR|UxRTFwMkK5NlQh|ryPMnzxV2FPT0WU
BHT-101NFXZTZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHLKdXRKSzVyPUGuNlM1QSEQvF2=NVno[VhwW0GQR1XS
SCC-25MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXnJR|UxRTFwMkO1N|Yh|ryPNYrsdHlPW0GQR1XS
NTERA-S-cl-D1NFeyR2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXjJR|UxRTFwMkSzOFYh|ryPNVjhfFlkW0GQR1XS
MKN28NWO0elNDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXLJR|UxRTFwMkW2N|Yh|ryPNEXIdYRUSU6JRWK=
KS-1MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1KyR2lEPTB;MT6yPFI3QSEQvF2=NHTnTlhUSU6JRWK=
NCI-H1734MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkGyTWM2OD1zLkK4PVE{KM7:TR?=NH7BNVVUSU6JRWK=
ES7MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYHJR|UxRTFwMkm1OFIh|ryPNGfUPWhUSU6JRWK=
NCI-H838M4r4eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVTJR|UxRTFwM{C2NVUh|ryPMnXZV2FPT0WU
HEC-1M{m2UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX\PNJRHUUN3ME2xMlM{PzV3IN88US=>MoTIV2FPT0WU
ME-180MkXjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDlPYFrUUN3ME2xMlM4QTl|IN88US=>MV\TRW5ITVJ?
MMAC-SFNV\1OHNST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4n3XmlEPTB;MT6zPVU6PSEQvF2=MoDIV2FPT0WU
IA-LMM2\mNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGjReXFKSzVyPUGuOFA6OTRizszNMl7QV2FPT0WU
MN-60MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{K1eGlEPTB;MT60N|EyPCEQvF2=NXHyS21LW0GQR1XS
SIMANFfjenFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmnGTWM2OD1zLkS4Olg4KM7:TR?=NF;Ue2lUSU6JRWK=
NCI-H1770NXPrdIE{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fqd2lEPTB;MT61NlA2PCEQvF2=M2PsR3NCVkeHUh?=
ONS-76MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmW2TWM2OD1zLkWyN|EyKM7:TR?=M{Tx[HNCVkeHUh?=
LB771-HNCMmW3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MomxTWM2OD1zLkWzPVA3KM7:TR?=MX3TRW5ITVJ?
SW48M3ToS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHi1b|dKSzVyPUGuOVQzPDNizszNM1S1RXNCVkeHUh?=
KYSE-140M364cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3uTWM2OD1zLkW1O|QyKM7:TR?=NV;renYyW0GQR1XS
SW626MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4KwbWlEPTB;MT61PFE3KM7:TR?=NEnNVmZUSU6JRWK=
MC-CARM{LKOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGjSN4lKSzVyPUGuOVg3PjNizszNM2TufnNCVkeHUh?=
D-336MGNGHlXJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTabZRwUUN3ME2xMlYzQTRizszNMWfTRW5ITVJ?
SK-MEL-3NWGwbY5RT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWPR[lByUUN3ME2xMlY{QTB{IN88US=>MYrTRW5ITVJ?
MHH-PREB-1NEnZbXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXvJR|UxRTFwNkS0O|Mh|ryPMXTTRW5ITVJ?
Calu-1NVrDdI9uT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXXJR|UxRTFwNkWzPFYh|ryPMYjTRW5ITVJ?
HCC1806MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV3JR|UxRTFwNk[2NVEh|ryPMmXIV2FPT0WU
A101DMn3HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml[0TWM2OD1zLk[2O|gyKM7:TR?=NX:3SXNXW0GQR1XS
A704NYfHd3pOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTFwNkizNVEh|ryPMUTTRW5ITVJ?
LB831-BLCMnO4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4TndmlEPTB;MT62PVg2PCEQvF2=NGHhNIpUSU6JRWK=
RL95-2NVXlZpFVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUXJR|UxRTFwN{G0OlMh|ryPM4jifXNCVkeHUh?=
RPMI-2650NX3QSYJKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk[1TWM2OD1zLkeyO|E6KM7:TR?=MXjTRW5ITVJ?
NH-12MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn72TWM2OD1zLkezOFI4KM7:TR?=NHLocHZUSU6JRWK=
AGSMnjPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVzJR|UxRTFwN{[zOVgh|ryPNYrlR4NUW0GQR1XS
NEC8NES5NIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MW\JR|UxRTFwN{i5PVUh|ryPNXfEZppQW0GQR1XS
NCI-H2009NEi5empIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVTJR|UxRTFwN{m3NlEh|ryPM1XmVHNCVkeHUh?=
A498Mn\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NELiXIdKSzVyPUGuPFEzQDJizszNMX7TRW5ITVJ?
NCI-H810NIi2Z4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWS1Opp{UUN3ME2xMlgyPjB4IN88US=>NGLpNZdUSU6JRWK=
SK-NEP-1NGi3e3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIj4bmVKSzVyPUGuPFM4PjdizszNNIf2cIVUSU6JRWK=
D-542MGNILiRWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIDjUXFKSzVyPUGuPFU5PTFizszNMmHiV2FPT0WU
KNS-42MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmXETWM2OD1zLki2NlY3KM7:TR?=MX7TRW5ITVJ?
NCI-H2452MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGjZdHdKSzVyPUGuPFkxPzRizszNMkC3V2FPT0WU
SK-MEL-2MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWrSNGc{UUN3ME2xMlkxOjdzIN88US=>NF20PHhUSU6JRWK=
OVCAR-5MkjwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWDJR|UxRTFwOUC2O|Uh|ryPMk[3V2FPT0WU
SNG-MM{POOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV:0cVh2UUN3ME2xMlk2QDV6IN88US=>NE\WN2lUSU6JRWK=
A673MoXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHTJTGxKSzVyPUGuPVc2OTZizszNNIDFV2RUSU6JRWK=
L-428NIjxVJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoHGTWM2OD1zLkm5NVc6KM7:TR?=MWHTRW5ITVJ?
KM-H2MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2\zZ2lEPTB;Mj6wNVA6KM7:TR?=M1TM[nNCVkeHUh?=
MC-IXCMnjlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{\LUmlEPTB;Mj6wNlI4OyEQvF2=NW\Ie49HW0GQR1XS
COLO-678MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXrJR|UxRTJwMESyNFch|ryPMnLDV2FPT0WU
MEL-JUSONX;Zd3lMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYfJR|UxRTJwMEe4OVEh|ryPMYXTRW5ITVJ?
HCC38M2TZdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXnKO|N6UUN3ME2yMlA5PDN|IN88US=>MXTTRW5ITVJ?
UACC-62MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYDJR|UxRTJwMEi4OVUh|ryPM2TydHNCVkeHUh?=
OAW-42MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmPxTWM2OD1{LkC5O|EyKM7:TR?=M1fXUHNCVkeHUh?=
LB996-RCCM4nCSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV\JR|UxRTJwMUO4NVch|ryPM2T3enNCVkeHUh?=
COR-L105MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnT4TWM2OD1{LkG2N|c{KM7:TR?=MVTTRW5ITVJ?
RCC10RGBMkS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVvJR|UxRTJwMUi1O|Yh|ryPM4HV[3NCVkeHUh?=
A431NWXU[2ZPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHfkOHlKSzVyPUKuNVkxOTlizszNMnvYV2FPT0WU
NCI-H292NIribWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3j1N2lEPTB;Mj6yN|k2OSEQvF2=NF:xe49USU6JRWK=
SK-UT-1MnHYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\o[|ZJUUN3ME2yMlM{OTh2IN88US=>MnPZV2FPT0WU
PANC-08-13M1LRbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTnc|M2UUN3ME2yMlM{OjN3IN88US=>M2DoS3NCVkeHUh?=
ST486M2q4SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFrqdXBKSzVyPUKuOFExPDhizszNMnnLV2FPT0WU
SJSA-1MknNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{TEfGlEPTB;Mj60NVI4OSEQvF2=NY[2e4VwW0GQR1XS
RKOMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkL0TWM2OD1{LkSyNFI6KM7:TR?=NV;YUGdHW0GQR1XS
NCI-H1793MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTJwNESwNlkh|ryPNFX6cYpUSU6JRWK=
639-VMWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVvJR|UxRTJwNEWzPFIh|ryPNH;YbmVUSU6JRWK=
ES3M2LGOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYLJR|UxRTJwNEm3N|ch|ryPM172SXNCVkeHUh?=
NCI-H1792NWO4fGllT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkS4TWM2OD1{LkW2PFI3KM7:TR?=M3\yPXNCVkeHUh?=
NCI-H1651NYr6VGF1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4LKUGlEPTB;Mj61PFIyKM7:TR?=NFi1PXpUSU6JRWK=
SN12CMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmC1TWM2OD1{LkW4OFg4KM7:TR?=MWXTRW5ITVJ?
COLO-679NVfqUJZET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXXzfINrUUN3ME2yMlU5PjB3IN88US=>M4jxbnNCVkeHUh?=
U-118-MGMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mle3TWM2OD1{LkW4PFczKM7:TR?=NXLHc3lTW0GQR1XS
Ramos-2G6-4C10NYHNOmprT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4PCfmlEPTB;Mj62OFgxPyEQvF2=NHrJ[XdUSU6JRWK=
HCT-15NYX6XmQyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX;CW|BnUUN3ME2yMlY5Pzl{IN88US=>MWjTRW5ITVJ?
MDA-MB-157M3mzN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGG3dFZKSzVyPUKuO|A4PDdizszNMYfTRW5ITVJ?
K5M17lb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYH2bJpmUUN3ME2yMlcyQDR3IN88US=>NWrrVJRyW0GQR1XS
MKN45MmnjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEXRU|lKSzVyPUKuO|M{PjZizszNNIf5XJJUSU6JRWK=
DMS-273M{TrcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRTJwN{W2N|Ih|ryPMUDTRW5ITVJ?
C8166MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkXvTWM2OD1{Lke4OVE{KM7:TR?=NYPNRZFyW0GQR1XS
Calu-3M1TTSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTJwN{i5Olkh|ryPMnjnV2FPT0WU
SNB75M{TDWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3P4NWlEPTB;Mj64PFU{PSEQvF2=NV3QWWFRW0GQR1XS
BFTC-905M13wUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\HTWM2OD1{LkmwNVkyKM7:TR?=M1HG[XNCVkeHUh?=
C-4-IIMX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV7KfW57UUN3ME2yMlkyOzV|IN88US=>NY\0V2RHW0GQR1XS
MS-1M4\pNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmfFTWM2OD1{Lkm2O|Y6KM7:TR?=M1XHN3NCVkeHUh?=
A375NGKwfGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfofGZLUUN3ME2zMlA5OTh2IN88US=>NI\mU4RUSU6JRWK=
KYSE-70MlrYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmnQTWM2OD1|LkC4PFgzKM7:TR?=M{PtTnNCVkeHUh?=
KYSE-510NY[5OphGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF\3VXlKSzVyPUOuNVA6QTVizszNMVjTRW5ITVJ?
LN-405NYDE[3BsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTNwMUO1NVgh|ryPNXXGSmRrW0GQR1XS
BOKUNHyyTmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVPJR|UxRTNwMUSyOVYh|ryPM3vCVnNCVkeHUh?=
TE-10NHTxT3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXmwXmNSUUN3ME2zMlE4OzZ{IN88US=>MWPTRW5ITVJ?
MKN1MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXjnOFF2UUN3ME2zMlE5PDh|IN88US=>NIO0eIZUSU6JRWK=
M059JNYPlOJB6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYnJR|UxRTNwMkCxO|Mh|ryPM2PSVHNCVkeHUh?=
GOTOM3\2V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn23TWM2OD1|LkKyNFM6KM7:TR?=NG\6NIxUSU6JRWK=
DK-MGMke2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXHRWpNzUUN3ME2zMlI2QTd4IN88US=>MWfTRW5ITVJ?
NCI-H727MkDFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\qZmpmUUN3ME2zMlI3PThizszNMk\IV2FPT0WU
NB12NYnOcXlbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFPTclRKSzVyPUOuN|MzOjRizszNMYfTRW5ITVJ?
DOKMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NI\0[nlKSzVyPUOuN|YyQDZizszNM2\rUHNCVkeHUh?=
KYSE-410NUnSb|h{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWjJR|UxRTNwM{[yPFch|ryPNYXDOY5tW0GQR1XS
AM-38NVeyU4VRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTNwM{iwOVEh|ryPM4nLXnNCVkeHUh?=
GR-STM1jQeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnHFTWM2OD1|LkS1O|MzKM7:TR?=MUHTRW5ITVJ?
D-247MGM2ToSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoHkTWM2OD1|LkS4NlY{KM7:TR?=NHS1eHFUSU6JRWK=
TE-8MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX7LOINKUUN3ME2zMlQ6OzN|IN88US=>MYLTRW5ITVJ?
LS-411NNXS1bnhJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MorqTWM2OD1|LkS5OlkzKM7:TR?=M1rpNHNCVkeHUh?=
SK-MES-1NY[0bFRoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUDyOZJ3UUN3ME2zMlU3PDN|IN88US=>M3zVW3NCVkeHUh?=
SF295Mo\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnfwTWM2OD1|Lk[xOVUzKM7:TR?=MWnTRW5ITVJ?
SK-MEL-30M{PZd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn;KTWM2OD1|Lk[1PVIyKM7:TR?=MWDTRW5ITVJ?
LB2241-RCCNIfnRXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3;tN2lEPTB;Mz62OlI3KM7:TR?=NGDLVnhUSU6JRWK=
PC-14MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUfJR|UxRTNwNk[0N|ch|ryPMV;TRW5ITVJ?
EW-7MmPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3vsfmlEPTB;Mz62O|Y6OyEQvF2=Mn\1V2FPT0WU
NMC-G1NEnRV|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3\XNGlEPTB;Mz63NVg{PyEQvF2=MWnTRW5ITVJ?
TE-441-TMkiwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmHHTWM2OD1|LkezNFI5KM7:TR?=NYTsRWtnW0GQR1XS
NCI-H1618NHiyVHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWLPdVFlUUN3ME2zMlgyQDd3IN88US=>NEfJeGVUSU6JRWK=
PANC-03-27NF3QdWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFyz[HJKSzVyPUOuPFE6OTZizszNNIjZUYhUSU6JRWK=
NCI-H2228NVTzeGZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvkcG83UUN3ME2zMlg{OTJ4IN88US=>MkG0V2FPT0WU
CAPAN-1Mn3tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXjJUml2UUN3ME2zMlg4ODB7IN88US=>M1jBfXNCVkeHUh?=
KLEM2G0PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGDhR21KSzVyPUOuPVA3PyEQvF2=NV\3dnhbW0GQR1XS
BeckerMlnZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2LncWlEPTB;Mz65Nlg1QSEQvF2=MWDTRW5ITVJ?
SK-PN-DWMmD2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTRwMEe5O|Qh|ryPNXnPOHk3W0GQR1XS
Hs-578-TNV;OeGJ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYnJR|UxRTRwMEizNFYh|ryPMmDpV2FPT0WU
RS4-11MoLjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTGTWM2OD12LkGxNlU2KM7:TR?=MkS1V2FPT0WU
D-502MGNEH5eFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVnhUINGUUN3ME20MlE3QTl5IN88US=>NUfmfI0{W0GQR1XS
GI-1NF;wO2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NETRdYdKSzVyPUSuNlgzQTlizszNM1jZcHNCVkeHUh?=
NCI-H209MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmnqTWM2OD12LkOzO|gh|ryPMWLTRW5ITVJ?
SK-OV-3NYi5R4U5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTRwNEixOFkh|ryPNFnWOHZUSU6JRWK=
LOUCYM3;ZUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnHXTWM2OD12LkS4OFMzKM7:TR?=MVzTRW5ITVJ?
NCI-H69MkTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4PF[WlEPTB;ND61NVc6OyEQvF2=MlzyV2FPT0WU
SCC-9M3rDUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4C4cGlEPTB;ND61N|E4OiEQvF2=M2rLd3NCVkeHUh?=
NCI-H526NYHWTWZyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYDJR|UxRTRwNUmyPVMh|ryPNEHhVZhUSU6JRWK=
NCI-H2170MnrCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnv2TWM2OD12Lk[2O|cyKM7:TR?=MnTCV2FPT0WU
SRNIXjdXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUfaWm85UUN3ME20MlcxODR6IN88US=>NHruRYFUSU6JRWK=
CMKMn\US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTRwN{KxNFEh|ryPMnfiV2FPT0WU
COLO-829M4juVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmfoTWM2OD12Lke3NFQ{KM7:TR?=NVrzVYVoW0GQR1XS
HuO-3N1Mn3SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVPWWW9CUUN3ME20Mlg{OjhzIN88US=>M2fnPXNCVkeHUh?=
5637NV\jfW5GT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlHiTWM2OD12LkmwOFg4KM7:TR?=MlTDV2FPT0WU
A253NYnYWWRmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWrGPG1XUUN3ME20Mlk4PzB6IN88US=>NVfXUGtHW0GQR1XS
NB10NGPGcXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NI\VUoZKSzVyPUWuNFc1QTdizszNM3rZW3NCVkeHUh?=
SF539MofPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLLTWM2OD13LkC5PVU6KM7:TR?=Mle2V2FPT0WU
HAL-01NVzTb|RpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTVwMUS2OFUh|ryPMVXTRW5ITVJ?
MHH-ES-1NULifZE3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIPmUYZKSzVyPUWuNVY6OjVizszNMVrTRW5ITVJ?
DELNXnsRXlzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmLTTWM2OD13LkK3OVgzKM7:TR?=M4jyZ3NCVkeHUh?=
NCI-H1299NWnpPXNiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEPlSnJKSzVyPUWuN|UxODdizszNM{\VdHNCVkeHUh?=
ChaGo-K-1NGHMbGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml6zTWM2OD13LkO1NVA4KM7:TR?=MWrTRW5ITVJ?
HMV-IIM4K1eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHz3SHJKSzVyPUWuN|k1OyEQvF2=M4jxXHNCVkeHUh?=
NB69MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUnPW3VOUUN3ME21MlM6PjNzIN88US=>MmjLV2FPT0WU
NCI-H1882MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3zaUmlEPTB;NT60N|M3PCEQvF2=MlX4V2FPT0WU
SNU-475MmTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIXDT5FKSzVyPUWuOFcyPzFizszNNWW3N2N{W0GQR1XS
RXF393NGL3WFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIPqXYZKSzVyPUWuOFg1QTRizszNMUTTRW5ITVJ?
CAL-51M{nOZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoLFTWM2OD13Lk[yPFU{KM7:TR?=NF;6RXFUSU6JRWK=
SW1573NFzhVI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3ewTmlEPTB;NT62N|U{PCEQvF2=MX;TRW5ITVJ?
GCTMWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFXlPJBKSzVyPUWuO|U6OjlizszNNGPsfVZUSU6JRWK=
COR-L88M1qyOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3\FfmlEPTB;NT63Olg1PiEQvF2=NUHFTotSW0GQR1XS
MDA-MB-134-VINED2Tm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NG\ZZVBKSzVyPUWuPFc2OzZizszNMU\TRW5ITVJ?
NB5MojBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTVwOUK0OEDPxE1?NH3KXYtUSU6JRWK=
GMS-10MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHrFc21KSzVyPUWuPVY5PjFizszNM1:0e3NCVkeHUh?=
CHP-212MnTPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoHmTWM2OD14LkS4NlY4KM7:TR?=MXfTRW5ITVJ?
TE-11Mn;RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmDmTWM2OD14LkW1NVgzKM7:TR?=MWHTRW5ITVJ?
SW962MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoPlTWM2OD14Lk[1O|c1KM7:TR?=NIPqV2xUSU6JRWK=
MZ2-MELNGCzTJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1XaNmlEPTB;Nj64NlAyOSEQvF2=M1;ZVnNCVkeHUh?=
C-33-AM4DTS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTZwOUG2PFgh|ryPM3SwZ3NCVkeHUh?=
IGR-1MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYDJR|UxRTZwOUe4NlYh|ryPNIXuV25USU6JRWK=
MOLT-4NGLxb|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX3xRm41UUN3ME23MlE2PDB4IN88US=>NInFUGhUSU6JRWK=
NCI-H1650MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4rvc2lEPTB;Nz6yO|A1PiEQvF2=M1LpW3NCVkeHUh?=
AsPC-1M1LxXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXzOWGVlUUN3ME23MlI5PjB3IN88US=>M4fxZXNCVkeHUh?=
SNU-C2BM1rjOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlL0TWM2OD15LkK5OVcyKM7:TR?=M2rXRXNCVkeHUh?=
MKN7NYfLSHNVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXrRXXB{UUN3ME23MlM4OjN3IN88US=>NFriNWpUSU6JRWK=
SW620M4XZfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4LWcWlEPTB;Nz6zPFIxPSEQvF2=MXPTRW5ITVJ?
SK-MEL-28MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmLMTWM2OD15LkSwO|k5KM7:TR?=MXfTRW5ITVJ?
TE-6M3vCe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4Xl[GlEPTB;Nz60OFkxQCEQvF2=M3T3TnNCVkeHUh?=
D-263MGNYXaW2E6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{nITWlEPTB;Nz60OVc3OiEQvF2=MUHTRW5ITVJ?
NCI-H1355Ml64S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTdwN{ewNlkh|ryPMkfJV2FPT0WU
DSH1MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVPJR|UxRTdwN{m3OlIh|ryPMX;TRW5ITVJ?
NCI-H460MmnqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M17jWmlEPTB;OD6wNFY6PCEQvF2=MXnTRW5ITVJ?
NCI-H1563NWfjTIlmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRThwMEe1NFgh|ryPNE\F[WtUSU6JRWK=
SW948NFTSXGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkPUTWM2OD16LkGwO|Q1KM7:TR?=M332dnNCVkeHUh?=
LK-2NEf5WmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDoTWM2OD16LkGyPFM{KM7:TR?=M2TvdXNCVkeHUh?=
HT-1080NVWzdpB2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkHNTWM2OD16LkGzNVc2KM7:TR?=NEf1V3BUSU6JRWK=
NCI-H441MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYrJR|UxRThwMUmzJO69VQ>?M36xRXNCVkeHUh?=
HSC-4MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NI\RZ|BKSzVyPUiuNlg4OiEQvF2=MVXTRW5ITVJ?
LXF-289NV7xUlN5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVTJR|UxRThwM{W5OFMh|ryPMoDUV2FPT0WU
MRK-nu-1NVHvT2d4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXfR[JFYUUN3ME24MlM3OzB2IN88US=>NYjiT2QyW0GQR1XS
no-11NWHBV5RjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXrJR|UxRThwNEexN|Mh|ryPMVvTRW5ITVJ?
SNU-387NF3SNlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWi4dWZMUUN3ME24MlY{OjR4IN88US=>M3;QdnNCVkeHUh?=
Detroit562NVvqOJQzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRThwN{W0OVUh|ryPM2LzVXNCVkeHUh?=
SW954MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHnpcVhKSzVyPUiuO|Y5OzJizszNNFnxTGNUSU6JRWK=
P12-ICHIKAWAM3fncWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVTJR|UxRThwN{i5OEDPxE1?NGnVOZRUSU6JRWK=
TE-9M1Kwc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILqO3RKSzVyPUiuPFExPjJizszNNFjuemlUSU6JRWK=
NB13NX\INo13T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1r0O2lEPTB;OD64N|c6PiEQvF2=MnLSV2FPT0WU
BPH-1M33XSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWXHeGFZUUN3ME24Mlg2ODhzIN88US=>MXTTRW5ITVJ?
KMOE-2MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrZUpdKSzVyPUiuPFc5QTJizszNNH\NNlRUSU6JRWK=
RPMI-8402NXO1bmlWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33HT2lEPTB;OD64PVkzPiEQvF2=NIPSNFJUSU6JRWK=
OVCAR-3MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELhelRKSzVyPUiuPVc4OzJizszNNULIfXVDW0GQR1XS
NCI-H2196Mm[wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{DKWWlEPTB;OD65PFYxPiEQvF2=NV;xcI9lW0GQR1XS
MZ7-melNVu3fJlGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3W0SmlEPTB;OT6wN|Q3KM7:TR?=MlrEV2FPT0WU
GP5dMlXUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2iwSWlEPTB;OT6wOlMyOyEQvF2=MVPTRW5ITVJ?
NCI-N87NGPa[|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmnDTWM2OD17LkS0O|MyKM7:TR?=MmjNV2FPT0WU
EW-16MnjQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFXvXIJKSzVyPUmuOFQ5PDhizszNMnOwV2FPT0WU
Calu-6M37vNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnXCTWM2OD17LkS5O|A{KM7:TR?=Mon1V2FPT0WU
LC4-1MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYnBSohSUUN3ME25MlYzPTdizszNMkPKV2FPT0WU
CCRF-CEMMWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVTyUXJQUUN3ME25MlY5PzZ4IN88US=>NWrkdIpbW0GQR1XS
BC-1MnrsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{n0[GlEPTB;OT63PFk6KM7:TR?=MmX5V2FPT0WU
NCI-SNU-16MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{PkSmlEPTB;OT63PVQ6PSEQvF2=NVnze3lKW0GQR1XS
NCI-H28MoO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHXxV|VKSzVyPUmuPFQ6OzNizszNNGrYcIhUSU6JRWK=
SBC-1NGW4TnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVrrPZQ1UUN3ME2xNE4xPzJizszNNI\tW4dUSU6JRWK=
TURNXiyS25xT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoTBTWM2OD1zMD6xOlU4KM7:TR?=NH7RWoFUSU6JRWK=
MDA-MB-231MoTDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MorPTWM2OD1zMD6yNVE1KM7:TR?=NIPB[W9USU6JRWK=
C3ANF76TZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{O2S2lEPTB;MUCuN|E4QSEQvF2=M1vSXXNCVkeHUh?=
SW1990NH\UVGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnvFTWM2OD1zMD6zNlgh|ryPMojzV2FPT0WU
NCI-H1993M1TRd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTFyLkW2PVMh|ryPMWPTRW5ITVJ?
SK-CO-1MofIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmniTWM2OD1zMD63O|ch|ryPMV;TRW5ITVJ?
OAW-28MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HsVWlEPTB;MUCuPVg5QCEQvF2=MoC0V2FPT0WU
HNNUXsS|ZPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV;lVmVvUUN3ME2xNU4yOTNzIN88US=>NETyU|ZUSU6JRWK=
NCI-H1304MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4nJdWlEPTB;MUGuNVU4PiEQvF2=MXrTRW5ITVJ?
DaoyM2Xke2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF7ONWJKSzVyPUGxMlQ{OzZizszNM3TsSnNCVkeHUh?=
VA-ES-BJM4HnTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGPFZVdKSzVyPUGxMlcyQTVizszNNHHDTJhUSU6JRWK=
MCF7NFi0O2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4fSZmlEPTB;MUGuPFEzPiEQvF2=M3L0VXNCVkeHUh?=
VM-CUB-1Ml3JS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTFzLkmwPVEh|ryPMnjVV2FPT0WU
IPC-298MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXvJR|UxRTFzLkmzPFMh|ryPM2Dae3NCVkeHUh?=
NCI-H2126MkX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnzNTWM2OD1zMj6wNlE5KM7:TR?=NVnCTHR{W0GQR1XS
OVCAR-8Ml3NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHq2TXFKSzVyPUGyMlEyPDFizszNNIDaTJNUSU6JRWK=
SJRH30MmPVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIjBPZlKSzVyPUGyMlIzQTlizszNMkTYV2FPT0WU
DMS-53MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVnJR|UxRTF{LkK2OFkh|ryPNGHCdlVUSU6JRWK=
NCI-H322MNVX4TWhDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX;seXBCUUN3ME2xNk4{OzV5IN88US=>NF7aPXhUSU6JRWK=
RVH-421MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIW0cYxKSzVyPUGyMlQ6ODRizszNMYfTRW5ITVJ?
RajiMnjFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVfJR|UxRTF{Lk[xOEDPxE1?MUDTRW5ITVJ?
MDA-MB-415NYTGWng4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGTtWnRKSzVyPUGyMlY1PDRizszNNUHjPIZkW0GQR1XS
EFE-184NGS4bZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnXZTWM2OD1zMj63NVA3KM7:TR?=NWLFWnR{W0GQR1XS
BFTC-909NV\yUmI3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnzDTWM2OD1zMj65NlQ4KM7:TR?=NYO5ZmI3W0GQR1XS
BHYNHnEe25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFH4PI1KSzVyPUGzMlM{QSEQvF2=Ml[0V2FPT0WU
YKG-1NVPWRZpnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGHGbWJKSzVyPUGzMlM4PDlizszNNWH5e|FWW0GQR1XS
EW-3M3;oZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2\iTWlEPTB;MUOuO|E3OyEQvF2=MknyV2FPT0WU
HCC1143M4i1SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnroTWM2OD1zMz63OFM4KM7:TR?=NYn3eYpGW0GQR1XS
REHMnPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3jnRWlEPTB;MUOuPFk5OiEQvF2=M2LUUHNCVkeHUh?=
CESSMn\BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWWweI85UUN3ME2xN{46PDh7IN88US=>MYDTRW5ITVJ?
EFM-19M3jOcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4P6OWlEPTB;MUSuNVEyOiEQvF2=MoLoV2FPT0WU
U031MmHqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYTIUppxUUN3ME2xOE41ODh3IN88US=>MoHJV2FPT0WU
ES1NEnC[JVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mkn2TWM2OD1zND60PFUyKM7:TR?=MnPJV2FPT0WU
HSC-3MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4nPcWlEPTB;MUSuOlIyPSEQvF2=MnOyV2FPT0WU
LOXIMVINEj5e5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTF2LkewOlgh|ryPMV\TRW5ITVJ?
A388MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{Dw[WlEPTB;MUSuO|U2PiEQvF2=NIj1SnJUSU6JRWK=
KP-N-YSNGLZOGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWS4dVdoUUN3ME2xOE44PzNizszNMlH3V2FPT0WU
Capan-2M2PPXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\qTWM2OD1zND63PFYh|ryPNGDQU4FUSU6JRWK=
SKG-IIIaNFSzO25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2O4bmlEPTB;MUSuPFg3OiEQvF2=NV63SGFZW0GQR1XS
HELNVPsNIJjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2X0N2lEPTB;MUSuPFk6PyEQvF2=MVPTRW5ITVJ?
BENMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXLJR|UxRTF2Lkm3OlYh|ryPNFrqTYxUSU6JRWK=
MC116MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHlTWM2OD1zNT6xOVk6KM7:TR?=NU\zPIU5W0GQR1XS
IGROV-1M3HOemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUTvdnF3UUN3ME2xOU4zOzF5IN88US=>MmLPV2FPT0WU
NCI-H1648NIrzO|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mlm5TWM2OD1zNT61N|A2KM7:TR?=NInsU21USU6JRWK=
ABC-1NYDTWFY3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NELOUFlKSzVyPUG1MlgxOzNizszNM4fEcXNCVkeHUh?=
EW-18M4nyUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoK1TWM2OD1zNT65PVc6KM7:TR?=NX\1VpdZW0GQR1XS
BC-3MknSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIS3SVNKSzVyPUG2MlA2PjJizszNMYTTRW5ITVJ?
NCI-H1437MknsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGXLZmlKSzVyPUG2MlA3PjdizszNMor4V2FPT0WU
SCC-15MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1\LO2lEPTB;MU[uNlgzPSEQvF2=M4\YcXNCVkeHUh?=
TTMl\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2XSTWlEPTB;MU[uOVg5QCEQvF2=NXXHdWVvW0GQR1XS
KINGS-1NULiZ4R5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGHURmxKSzVyPUG2MlgzPzNizszNMYjTRW5ITVJ?
C32NH3zT3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVe3eZp6UUN3ME2xOk46PzF5IN88US=>NV25XGJ3W0GQR1XS
SBC-5NHTsNoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV\sbnZZUUN3ME2xO{4yPDd7IN88US=>NXvxd45LW0GQR1XS
NB1MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4DBSWlEPTB;MUeuN|E5QCEQvF2=MkXiV2FPT0WU
EB-3NIXUOHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGjwOIVKSzVyPUG3MlU4PiEQvF2=NEjs[IFUSU6JRWK=
NCI-H748MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUjJR|UxRTF5LkewN|Uh|ryPM{PQSXNCVkeHUh?=
IST-SL1Mn;US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LFRWlEPTB;MUeuO|UzPiEQvF2=MWTTRW5ITVJ?
WM-115NV\hW5ZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWrIUIJ2UUN3ME2xO{45ODh3IN88US=>NIfvSG1USU6JRWK=
NCI-H226NYTzcIVMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1\nO2lEPTB;MUeuPVU1PiEQvF2=MWjTRW5ITVJ?
CAL-33NEH1bWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYfJR|UxRTF6LkK3PFEh|ryPNYXsUZpjW0GQR1XS
SCC-4NV6xN3F4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEL0[HFKSzVyPUG4MlMzOjlizszNM4XwW3NCVkeHUh?=
RMG-IM2nBeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3zoUGlEPTB;MUiuOlk1PyEQvF2=NGjrWY1USU6JRWK=
KOSC-2NXzvZYk4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1jq[WlEPTB;MUiuO|c1PiEQvF2=M{nhcHNCVkeHUh?=
A2058M373bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHTl[GFKSzVyPUG4MlgzPTVizszNMVzTRW5ITVJ?
HCC70MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mk\aTWM2OD1zOT6zPFk1KM7:TR?=NUDabplWW0GQR1XS
C2BBe1NXizRWpST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2PHU2lEPTB;MUmuOFE1QCEQvF2=MonrV2FPT0WU
NCI-H650M33yUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXi1eoQ5UUN3ME2xPU42QDl7IN88US=>MWfTRW5ITVJ?
CAL-72M4jCSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVrSfoJJUUN3ME2xPU43PzN5IN88US=>MlPaV2FPT0WU
L-363MoHQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn7hTWM2OD1{MD6wNlEzKM7:TR?=NH7OWWhUSU6JRWK=
SNU-423NEfyRmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFn5eVZKSzVyPUKwMlExPDNizszNMX3TRW5ITVJ?
PLC-PRF-5NYW4cmoyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnziTWM2OD1{MD6zPVA3KM7:TR?=NF7Q[mdUSU6JRWK=
SW1463NGHQfnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUDJR|UxRTJyLkS1NlUh|ryPNXvRdmllW0GQR1XS
769-PM37UZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFfCW2NKSzVyPUKwMlY4PjlizszNMnjFV2FPT0WU
DMS-79Mo\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXm0N5hTUUN3ME2yNE45PDlizszNM2PKUXNCVkeHUh?=
Saos-2M1jTS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnP5TWM2OD1{MD65OVU3KM7:TR?=NXT6TnFEW0GQR1XS
CHP-126M1Txc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHnzNoFKSzVyPUKxMlQ1PjJizszNMn;IV2FPT0WU
SW837MkHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU[5dFZIUUN3ME2yNU41QTN7IN88US=>MXrTRW5ITVJ?
SHP-77MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHPPbmlKSzVyPUKxMlYyOjJizszNNUC3NWxZW0GQR1XS
DBNHXzVJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUfad3hpUUN3ME2yNU43OTR{IN88US=>M3fHSnNCVkeHUh?=
ES5NUm3VWtjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEGzfGxKSzVyPUKxMlY5PjRizszNMkLTV2FPT0WU
COR-L23NYq5[opZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm\qTWM2OD1{MT64NFUyKM7:TR?=NIT0W5VUSU6JRWK=
KU-19-19Mn;vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYXJR|UxRTJzLki5PFIh|ryPNHq2RWVUSU6JRWK=
T84MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEntS2FKSzVyPUKxMlk5OTlizszNMknpV2FPT0WU
NCI-H630NEDBW3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NITzWnhKSzVyPUKyMlU{PjNizszNNIn0THVUSU6JRWK=
LU-165NWm5e|BFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2DS[WlEPTB;MkKuOVU1KM7:TR?=Mn3vV2FPT0WU
COLO-792MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1HBZmlEPTB;MkKuO|EyOSEQvF2=MnTKV2FPT0WU
CAL-62M4XJWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTJ{Lke1NVch|ryPM2P2[3NCVkeHUh?=
HCE-TM1y2SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NELEdY1KSzVyPUKyMlg3ODZizszNMU\TRW5ITVJ?
BB65-RCCMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;lTWM2OD1{Mz6wN|Q1KM7:TR?=MYTTRW5ITVJ?
SiHaM2juSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTJ|LkO5Olgh|ryPM1m2dXNCVkeHUh?=
NCI-H2081M4O0NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{LLOmlEPTB;MkSuNFY1OSEQvF2=MoSzV2FPT0WU
U251MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGrHU5pKSzVyPUK0MlA3PjhizszNNUXNSGs2W0GQR1XS
LoVoMYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NE[zXnBKSzVyPUK0MlkzQDJizszNNEjYfnpUSU6JRWK=
GCIYNGj4UmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVTJR|UxRTJ3LkK4O|ch|ryPNVu5ZmM3W0GQR1XS
NUGC-3NIj0UZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn3ETWM2OD1{NT6zN|E3KM7:TR?=Ml;iV2FPT0WU
LNCaP-Clone-FGCNYXFOIQ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkS1TWM2OD1{NT6zOFk5KM7:TR?=MX\TRW5ITVJ?
PA-1MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIfURZFKSzVyPUK1MlY5OzNizszNNFjNW2NUSU6JRWK=
OE33MnvuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{fWRmlEPTB;MkWuOlg2OyEQvF2=NFvRVYFUSU6JRWK=
HT-29NH\3WmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{LpWWlEPTB;MkWuO|g4QSEQvF2=Mkm4V2FPT0WU
RCM-1NUS1fm1TT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHS0XZZKSzVyPUK1Mlk3PTZizszNMW\TRW5ITVJ?
NCI-H1522MkT0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFfENFFKSzVyPUK1Mlk6OTFizszNMX;TRW5ITVJ?
LB373-MEL-DNFzUWZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTJ4LkG3NFgh|ryPNGrKSJBUSU6JRWK=
NCI-H1436NE[3[mRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NI\hTJFKSzVyPUK2MlI4OzhizszNMWnTRW5ITVJ?
COLO-824M3\M[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXHJR|UxRTJ4LkSwNFIh|ryPMV\TRW5ITVJ?
CP50-MEL-BMkjMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVTJR|UxRTJ4LkW2O|Uh|ryPNUOyNFc4W0GQR1XS
EGI-1MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGL3c|RKSzVyPUK3MlI3QThizszNMmLRV2FPT0WU
LAN-6MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1rtRmlEPTB;MkeuN|U6QCEQvF2=NELyUZRUSU6JRWK=
GAKMlnlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHnSWZJKSzVyPUK3MlQzOjVizszNNF;OZ21USU6JRWK=
MDA-MB-175-VIIMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1P4XGlEPTB;MkeuOVA2OyEQvF2=MVLTRW5ITVJ?
JVM-2NXzMTFBMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2S0bGlEPTB;MkeuOlYzOiEQvF2=MXzTRW5ITVJ?
UACC-257MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTJ5Lk[4O|gh|ryPMkTHV2FPT0WU
SW1783NFns[2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3rIfGlEPTB;MkeuO|c5OyEQvF2=NI\ze49USU6JRWK=
HT-3MmXXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M37DcGlEPTB;MkiuNlE3PiEQvF2=NYPubopRW0GQR1XS
RLMlXFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWTHU3c3UUN3ME2yPE42QTFzIN88US=>MWnTRW5ITVJ?
TK10NGPpXI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUnB[GIzUUN3ME2yPE43PTN3IN88US=>MVXTRW5ITVJ?
HT55NV:zZnhYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFjWUYJKSzVyPUK5MlA2PjVizszNNGnjUpRUSU6JRWK=
BT-20M1\WNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoLhTWM2OD1{OT6wOVg3KM7:TR?=NVvacIxLW0GQR1XS
TGBC24TKBNYjpUZl6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYjWO49NUUN3ME2yPU4yQDNzIN88US=>M3HFXXNCVkeHUh?=
HSC-2NELZN3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NI\xNXhKSzVyPUK5MlMxODFizszNNVO5XVBuW0GQR1XS
COLO-205M364R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFT1[2xKSzVyPUK5MlM6PDRizszNMWTTRW5ITVJ?
GT3TKBMojRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU[3ZYU3UUN3ME2yPU43QDd5IN88US=>Ml\IV2FPT0WU
T47DMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnW1TWM2OD1{OT64OVgzKM7:TR?=MX\TRW5ITVJ?
OMC-1MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnfGTWM2OD1|MD6xPVE6KM7:TR?=MkfYV2FPT0WU
PFSK-1MlLYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVPJR|UxRTNzLkK2OVkh|ryPNF3aeJNUSU6JRWK=
JEG-3M1rMbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1LaVmlEPTB;M{GuN|U3OSEQvF2=MUfTRW5ITVJ?
RDMlKyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnz1TWM2OD1|MT61NVE2KM7:TR?=MnvOV2FPT0WU
NCI-H64MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTN{LkSxO|kh|ryPNEPOXHRUSU6JRWK=
DMS-114NWTINGpCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXm5Wnk2UUN3ME2zNk41OTh{IN88US=>NIPMXphUSU6JRWK=
NCI-H661NH\2eZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml:4TWM2OD1|Mj62OVAyKM7:TR?=NYHVemd3W0GQR1XS
CAL-148NYHiSHc{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnHmTWM2OD1|Mj62OlY2KM7:TR?=NVjI[W9HW0GQR1XS
HuP-T3NXHRNnBNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4PTemlEPTB;M{KuPVM{QCEQvF2=MlzDV2FPT0WU
ES4NYfUclFRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\xTWM2OD1|Mz6xO|A2KM7:TR?=M1HjN3NCVkeHUh?=
Ca9-22NHHje|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1vLXWlEPTB;M{OuOFYxOSEQvF2=MWPTRW5ITVJ?
LP-1MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX7SZ4hxUUN3ME2zOE4xQSEQvF2=MoK5V2FPT0WU
AU565M4L2cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFTZOYVKSzVyPUO0MlUxPjlizszNNXzTOXlPW0GQR1XS
MDA-MB-453NWPpWlRqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4\uV2lEPTB;M{WuNVQzPiEQvF2=NVexNWk3W0GQR1XS
SNU-C1MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHrkO25KSzVyPUO1MlE4OSEQvF2=NIDhN4VUSU6JRWK=
SW13M17JWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUfJR|UxRTN3LkSwO|Yh|ryPM4rPcnNCVkeHUh?=
NCI-H2122MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm\PTWM2OD1|NT61OVk5KM7:TR?=MnexV2FPT0WU
NCI-H1395NYPJVmJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXzLR|RuUUN3ME2zOU43PjlzIN88US=>MW\TRW5ITVJ?
J-RT3-T3-5MnPwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MojCTWM2OD1|Nj6wNlk1KM7:TR?=M4j3XnNCVkeHUh?=
COR-L279M3LxWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXvTWM2OD1|Nj6xPVgyKM7:TR?=MoX4V2FPT0WU
ATN-1MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVTOOJc3UUN3ME2zOk45PTF4IN88US=>MUfTRW5ITVJ?
HCC2998MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmjUTWM2OD1|Nj64OVcyKM7:TR?=NIXJdHpUSU6JRWK=
UM-UC-3NVW1[JMzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MofiTWM2OD1|Nj64Olc2KM7:TR?=M{TPc3NCVkeHUh?=
DV-90NFOwcIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NV\3OGJLUUN3ME2zOk46ODZ5IN88US=>NF3PO4pUSU6JRWK=
ES8NYDvcG5OT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYfCfoc{UUN3ME2zOk46OzF6IN88US=>MoS0V2FPT0WU
YAPCNIrIdmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV7JR|UxRTN4Lkm2OVQh|ryPMWfTRW5ITVJ?
HCC1599MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUfHO4JGUUN3ME2zO{4yPjF6IN88US=>MkLDV2FPT0WU
UMC-11NVL2UWo{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVuwSHNzUUN3ME2zO{4zPTB|IN88US=>NVXLbZZqW0GQR1XS
THP-1M4PrWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYewd3lPUUN3ME2zO{4zQDZ6IN88US=>M3riXnNCVkeHUh?=
OCUB-MM1H3d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHfVfIdKSzVyPUO3MlI5QTFizszNMXvTRW5ITVJ?
NCI-H1693MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFjOWodKSzVyPUO3MlMzOzNizszNMnzTV2FPT0WU
NCI-H345MlrRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkLkTWM2OD1|Nz6zOlI1KM7:TR?=M4jqTXNCVkeHUh?=
COLO-800MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVPJR|UxRTN5LkW2O{DPxE1?Mn3nV2FPT0WU
COLO-320-HSRNFPXVIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUD4Npo3UUN3ME2zPE4{PDl{IN88US=>M4TMUXNCVkeHUh?=
NCI-H596NYHUSmFuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4KyOmlEPTB;M{iuOFQ5QSEQvF2=NXzrb45bW0GQR1XS
NCI-H187NUO2dYgxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXTIS3BKUUN3ME2zPE44OzR2IN88US=>MXLTRW5ITVJ?
ECC4Ml7QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV6zdZdVUUN3ME2zPU4xQDF2IN88US=>MVfTRW5ITVJ?
KP-4M336XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3JTWM2OD1|OT6xNlM2KM7:TR?=M2W0OnNCVkeHUh?=
NCI-H2227MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF\QU21KSzVyPUO5MlM6PDlizszNMUPTRW5ITVJ?
22RV1NWrZV2VzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXHROIN2UUN3ME2zPU45Ozl6IN88US=>M1HGTnNCVkeHUh?=
SASMl:3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVrJR|UxRTRyLkC5OkDPxE1?Mn7NV2FPT0WU
PANC-10-05NVr5fJhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoHDTWM2OD12MD6xPFI5KM7:TR?=M2HRcnNCVkeHUh?=
MDA-MB-468NXLuW2UzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2S1V2lEPTB;NECuOVM1PiEQvF2=NWi0fJhJW0GQR1XS
RPMI-7951MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF3JTmtKSzVyPUSxMlIxPzVizszNMU\TRW5ITVJ?
BB49-HNCMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4PYTWlEPTB;NEGuNlE4QSEQvF2=MYTTRW5ITVJ?
23132-87NX7pUmdCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvzVFU{UUN3ME20NU4zPzN{IN88US=>NWPqN3FDW0GQR1XS
HCC1569NYrjRZN6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTRzLkK4PFUh|ryPMonpV2FPT0WU
CP66-MELMlfUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mon1TWM2OD12Mj6xPFg3KM7:TR?=MoHNV2FPT0WU
K-562MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXrUd2RWUUN3ME20Nk4zQDV2IN88US=>MV3TRW5ITVJ?
OCI-AML2MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFfuSYZKSzVyPUSyMlg6PzRizszNNU\BOnVCW0GQR1XS
SW756M{\jOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVTJR|UxRTR|LkCzPFgh|ryPNG\uVpVUSU6JRWK=
M14MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIPDRohKSzVyPUSzMlMyQDlizszNMV;TRW5ITVJ?
NCI-H1623NUn0ZZA4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTR|LkS2OEDPxE1?M3[zXnNCVkeHUh?=
KNS-81-FDNVnBVHhlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYnJR|UxRTR|Lke2NkDPxE1?M3H2dnNCVkeHUh?=
TGBC1TKBM3vxT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXrOOIVUUUN3ME20N{46ODl7IN88US=>NH3DOndUSU6JRWK=
RERF-LC-MSNID4T3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUXJR|UxRTR|LkmyPFEh|ryPNGDlVmhUSU6JRWK=
PC-3NUG3fHJDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoP3TWM2OD12ND60N|Q4KM7:TR?=NV7k[XlbW0GQR1XS
HuP-T4M4HzSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlHJTWM2OD12ND60OFc1KM7:TR?=MVHTRW5ITVJ?
NCI-H510AMlXmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYS4cXpbUUN3ME20OE44ODhizszNMmXJV2FPT0WU
LB2518-MELNYTHWYU4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUfpZ2R[UUN3ME20OE44QTN5IN88US=>M1nxeXNCVkeHUh?=
TE-5NWHz[nljT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXvJR|UxRTR3Lkm1PFEh|ryPMl;tV2FPT0WU
EW-24NUDvN2xkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4jZTGlEPTB;NE[uNVczOyEQvF2=NEHhPZVUSU6JRWK=
LB647-SCLCNFfOcm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHrXPVlKSzVyPUS2MlIyPTVizszNM4GzZXNCVkeHUh?=
NCI-H524NWPKWmdZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFrJTlFKSzVyPUS2MlcyQDVizszNM1nJSXNCVkeHUh?=
EW-11M3[4Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVzxOGIxUUN3ME20Ok46Ozd|IN88US=>M4\3W3NCVkeHUh?=
KALS-1NFvL[oVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVTZbYdGUUN3ME20O{4zODZ4IN88US=>NYnpNpJqW0GQR1XS
BT-474NUXKZWdxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{TDWmlEPTB;NEeuOFIyPiEQvF2=M4DHbnNCVkeHUh?=
SK-N-ASMnniS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmrQTWM2OD12Nz64PFgh|ryPNYL2[YRqW0GQR1XS
HCC2157NGPFbXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVzG[ZJyUUN3ME20PE4xPzZizszNNUnuUopIW0GQR1XS
HCC1954M1LwOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVTX[GVEUUN3ME20PE4yPzB2IN88US=>M2nHeHNCVkeHUh?=
FADUMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTR6LkOwN|Eh|ryPNWe0UHBCW0GQR1XS
S-117NUG3SGdoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVvyNoRoUUN3ME20PE4{QDF3IN88US=>NGHqRmtUSU6JRWK=
LS-1034NWT6cVNXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkT0TWM2OD12OD63NFY4KM7:TR?=MlTjV2FPT0WU
CAMA-1NIfoN5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3XBTWlEPTB;NEmuOVU1OyEQvF2=MXjTRW5ITVJ?
LU-134-AM{\YVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTR7LkiwPFUh|ryPMnvMV2FPT0WU
NCI-H1838NEXidY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrJR|UxRTR7LkiwPFch|ryPNVLNPXN3W0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo In a mouse xenograft model of Ba/F3 cells expressing native Bcr-Abl, AP24534 (2.5 mg/kg and 5 mg/kg) prolongs mice median survival. In the xenograft model of Ba/F3 Bcr-AblT315I, AP24534 (10 mg/kg–50 mg/kg) significantly suppresses tumor growth. AP24534 (30 mg/kg) decreases the phosphorylated Bcr-Abl and phosphorylated CrkL levels in the tumors. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Peptide substrate phosphorylation assays with GST-Abl kinase domains The effect of AP24534 (0-320 nM) on GST-Abl kinase activity is assessed by using a synthetic peptide substrate (Abltide: EAIYAAPFAKKK). Assays are carried out at 30 °C for 15 min in 25 μL reaction mixture: 8 mM MOPS (pH 7), 0.2 mM EDTA, 50 μM Abltide, 30 mM MgCl2, 10 mM β-glycerol phosphate, 1 mM EGTA, 0.002% Brij-35, 0.4 mM DTT, 0.2 mg/mL BSA, 0.4 mM sodium orthovanadate, 10 nM WT or mutant GST-Abl kinase, and 100 µM ATP/γ-32[P]ATP (5000 cpm/pmol). Reactions are terminated by transferring a portion of the reaction mixture onto a p81 phosphocellulose filter and immersing in 0.75% phosphoric acid. Filters are washed 3 times in 0.75% phosphoric acid, rinsed in acetone, and air dried; phosphate incorporation is determined by scintillation counting. All results are corrected for background binding to the filters, as determined by omitting peptide substrate from the kinase reaction. Time course experiments to establish the linear range of enzymatic activity precedes kinase assays.

Cell Assay: [2]

Cell lines Ba/F3 cells expressing Bcr-Abl or a range of single mutations in the kinase domain of Bcr-Abl
Concentrations 0-625 nM
Incubation Time 72 hours
Method Ba/F3 cell lines are distributed in 96-well plates (4 × 103 cells/well) and incubated with AP24534 for 72 hours. Proliferation is measured using a methanethiosulfonate (MTS)-based viability assay (CellTiter96 Aqueous One Solution). All values are normalized to the control wells with no drug. IC50 values are reported as the mean of three independent experiments performed in quadruplicat

Animal Study: [1]

Animal Models Mouse xenograft models of Ba/F3 cells expressing Bcr-Abl or Bcr-AblT315I
Formulation Dissolved in 25 mM citrate buffer, pH 2.75
Dosages 2.5 mg/kg and 5 mg/kg for Ba/F3 Bcr-Abl; 2.5 mg/kg–50 mg/kg for Ba/F3 Bcr-AblT315I
Administration Oral gavage once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] O'Hare T, et al. Cancer Cell, 2009, 16(5), 401-412.

[2] Huang WS, et al. J Med Chem, 2010, 53(12), 4701-4719.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-06-25)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT02776605 Not yet recruiting ALL PETHEMA Foundation June 2016 Phase 2
NCT01888562 Withdrawn Endometrial Neoplasms Washington University School of Medicine January 2016 --
NCT02627677 Recruiting Chronic Phase Chronic Myeloid Leukemia Ariad Pharmaceuticals December 2015 Phase 3
NCT02398825 Not yet recruiting Chronic Myeloid Leukemia|Chronic Phase|Adults Gruppo Italiano Malattie EMatologiche dellAdulto December 2015 Phase 2
NCT02779283 Recruiting Untreated Adult Acute Myeloid Leukemia OHSU Knight Cancer Institute|National Cancer Institute (NCI) December 2015 Phase 1

view more

Chemical Information

Download Ponatinib (AP24534) SDF
Molecular Weight (MW) 532.56
Formula

C29H27F3N6O

CAS No. 943319-70-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 30 mg/mL (56.33 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 10 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Customer Product Validation(2)


Click to enlarge
Rating
Source Cancer Cell 2012 22(5), 656-667 . Ponatinib (AP24534) purchased from Selleck
Method Western blot
Cell Lines RCH-ACV cells
Concentrations 50 nM
Incubation Time 1-24 h
Results Treatment of these cells with a CSK inhibitor (BMS-599626) or a BTK inhibitor (PCI-32765) did not recapitulate the dasatinib/ponatinib phenotype.

Click to enlarge
Rating
Source Genome Biol, 2014, 15(8): 428 . Ponatinib (AP24534) purchased from Selleck
Method Cell Proliferation Assay
Cell Lines KatoIII cells
Concentrations 0-0.5 nM
Incubation Time
Results Each of the inhibitors demonstrated a statistically significant lower IC50 in FGFR2-amplified KatoIII cells compared to non-FGFR2-amplified AGS cells at all concentrations tested.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Bcr-Abl Products

  • PX-478 2HCl

    PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. Phase 1.

  • Defactinib (VS-6063, PF-04554878)

    Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.

  • SU6656

    SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.

  • Imatinib Mesylate (STI571)

    Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM in cell-free or cell-based assays, respectively.

  • Nilotinib (AMN-107)

    Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine myeloid progenitor cells.

    Features:A selective inhibitor of native and mutant Bcr-Abl.

  • Bafetinib (INNO-406)

    Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM/19 nM in cell-free assays, does not inhibit the phosphorylation of the T315I mutant and is less potent to PDGFR and c-Kit. Phase 2.

    Features:Dual Bcr-Abl/Lyn inhibitor.

  • Degrasyn (WP1130)

    Degrasyn (WP1130) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).

    Features:WP1130 has an advantage over imatinib mesylate in that its activity is not inhibited by a variety of Abl kinase mutations, including T315I.

  • DCC-2036 (Rebastinib)

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Features:A conformational control inhibitor of Abl1 and T315I Abl1.

  • GZD824 Dimesylate

    GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

  • GNF-2

    GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.

Recently Viewed Items

Tags: buy Ponatinib (AP24534) | Ponatinib (AP24534) ic50 | Ponatinib (AP24534) price | Ponatinib (AP24534) cost | Ponatinib (AP24534) solubility dmso | Ponatinib (AP24534) purchase | Ponatinib (AP24534) manufacturer | Ponatinib (AP24534) research buy | Ponatinib (AP24534) order | Ponatinib (AP24534) mouse | Ponatinib (AP24534) chemical structure | Ponatinib (AP24534) mw | Ponatinib (AP24534) molecular weight | Ponatinib (AP24534) datasheet | Ponatinib (AP24534) supplier | Ponatinib (AP24534) in vitro | Ponatinib (AP24534) cell line | Ponatinib (AP24534) concentration | Ponatinib (AP24534) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us